These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 32470789)

  • 21. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
    Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
    Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphopenia during the COVID-19 infection: What it shows and what can be learned.
    Tavakolpour S; Rakhshandehroo T; Wei EX; Rashidian M
    Immunol Lett; 2020 Sep; 225():31-32. PubMed ID: 32569607
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond.
    Hasanagic S; Serdarevic F
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32554535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity, COVID-19 and immunotherapy: the complex relationship!
    Finelli C
    Immunotherapy; 2020 Oct; 12(15):1105-1109. PubMed ID: 32677493
    [No Abstract]   [Full Text] [Related]  

  • 25. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications.
    Loganathan S; Athalye SN; Joshi SR
    Expert Opin Biol Ther; 2020 Sep; 20(9):1025-1031. PubMed ID: 32700604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Management of Cytokine Storm in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine Storm in COVID19: A Neural Hypothesis.
    Ur A; Verma K
    ACS Chem Neurosci; 2020 Jul; 11(13):1868-1870. PubMed ID: 32605374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
    Langer-Gould A; Smith JB; Gonzales EG; Castillo RD; Figueroa JG; Ramanathan A; Li BH; Gould MK
    Int J Infect Dis; 2020 Oct; 99():291-297. PubMed ID: 32768693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19.
    Tindle HA; Newhouse PA; Freiberg MS
    Nicotine Tob Res; 2020 Aug; 22(9):1669-1670. PubMed ID: 32383751
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and the nicotinic cholinergic system.
    Farsalinos K; Angelopoulou A; Alexandris N; Poulas K
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32444400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic α7 nAChR signaling suppresses SARS-CoV-2 infection and inflammation in lung epithelial cells.
    Wen J; Sun J; Tang Y; Zhao J; Su X
    J Mol Cell Biol; 2024 Jan; 15(7):. PubMed ID: 37491690
    [No Abstract]   [Full Text] [Related]  

  • 32. A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19.
    González-Rubio J; Navarro-López C; López-Nájera E; López-Nájera A; Jiménez-Díaz L; Navarro-López JD; Nájera A
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33050574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).
    Simons D; Shahab L; Brown J; Perski O
    Addiction; 2021 Jun; 116(6):1319-1368. PubMed ID: 33007104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking and COVID-19: Did we overlook representativeness?
    Wenzl T
    Tob Induc Dis; 2020; 18():89. PubMed ID: 33149732
    [No Abstract]   [Full Text] [Related]  

  • 35. Nicotine and the nicotinic cholinergic system in COVID-19.
    Tizabi Y; Getachew B; Copeland RL; Aschner M
    FEBS J; 2020 Sep; 287(17):3656-3663. PubMed ID: 32790936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic receptors in airway disease.
    Borkar NA; Thompson MA; Bartman CM; Khalfaoui L; Sine S; Sathish V; Prakash YS; Pabelick CM
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L149-L163. PubMed ID: 38084408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential value of neuroimmunotherapy for COVID-19: efficacies and mechanisms of vagus nerve stimulation, electroacupuncture, and cholinergic drugs.
    Yu X; Kong Q
    Front Immunol; 2023; 14():1197467. PubMed ID: 37475861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors.
    O'Brien BCV; Weber L; Hueffer K; Weltzin MM
    J Biol Chem; 2023 May; 299(5):104707. PubMed ID: 37061001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.
    Shelukhina I; Siniavin A; Kasheverov I; Ojomoko L; Tsetlin V; Utkin Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of Cardiac Injury in COVID-19 Patients with Acute Ischaemic Stroke: What Do We Know So Far?-A Review of the Current Literature.
    Schoene D; Schnekenberg LG; Pallesen LP; Barlinn J; Puetz V; Barlinn K; Siepmann T
    Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.